Free webinar: A (wasted) opportunity to reduce diversion: how to overcome barriers to controlled substance waste reduction



Type of event:


This educational activity will review the peer-reviewed literature relating to the selection and use of manufacturer-prepared ready-to-administer (RTA) and traditional vial products on the basis of safety, waste, and workforce considerations. Common barriers and solutions to reduction of controlled substance IV push waste will be reviewed. The importance of incorporating cost-effectiveness data into purchasing decisions will also be described as they relate to improving care, reducing diversion, enhancing patient safety, and maximizing resources.

Presented by Speakers

Photo of John Hertig, IHFDA Webinar Speaker

John B. Hertig, PharmD, MS, CPPS, FASHP, FFIP

Chair and an Associate Professor of Pharmacy Practice in the Butler University College of Pharmacy and Health Sciences

John B. Hertig is the Chair and an Associate Professor of Pharmacy Practice in the Butler University College of Pharmacy and Health Sciences (Indianapolis, USA). Dr. Hertig lectures around the world and publishes on a variety of patient safety, leadership, administration, and health policy topics.  He serves as an Associate Editor for the Journal of Medicine Access, and his extensive research program is designed to enhance the safety of the medication use process, while using evidence to inform patient advocacy efforts. Dr. Hertig is a Member of the United States Food and Drug Administration Drug Safety and Risk Management Advisory Committee. He holds other national and international appointments, including with the International Pharmaceutical Federation, where he is Treasurer for the Hospital Pharmacy Section, and is Past-President of the Board of Directors for the Alliance for Safe Online Pharmacies – Global (ASOP), where he leads efforts to reduce the patient safety impact of illegal and counterfeit online drug distribution worldwide.  He was awarded the ASOP Global Patient Safety Champion Award in 2018.  Dr. Hertig received his Bachelor of Science in Pharmaceutical Sciences and Doctor of Pharmacy degrees from Purdue University (USA). He completed a PGY1 pharmacy practice and PGY2 health-system pharmacy administration residency at The Ohio State University Medical Center while also obtaining a Masters degree in Health-System Pharmacy Administration from The Ohio State University (USA).